BIOMAT Database Logo BIOMAT Database Logo

Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment. 1973

P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C

Related Publications

P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Immunological studies on Burkitt's lymphoma.
March 1971, Postgraduate medical journal,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
EVB-associated immune complexes and recurrent Burkitt's lymphoma.
January 1978, IARC scientific publications,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Burkitt's lymphoma - a human tumor model system for immunological studies.
December 1975, Biochimica et biophysica acta,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Further studies on the treatment of Burkitt's lymphoma.
June 1966, East African medical journal,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Immunological aspects of Burkitt's lymphoma.
January 1971, Advances in immunology,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
[Immunological problems in Burkitt's lymphoma].
May 1968, Saishin igaku. Modern medicine,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Treatment of Burkitt's lymphoma during pregnancy.
November 2006, The Annals of pharmacotherapy,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
[Cytogenetic and immunological studies of 5 cases of Burkitt's lymphoma-leukemia].
August 1983, [Rinsho ketsueki] The Japanese journal of clinical hematology,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
[A case of Burkitt's lymphoma].
May 1980, Revista espanola de las enfermedades del aparato digestivo,
P Gunvén, and G Klein, and W Henle, and G Henle, and G Rocchi, and J F Hewetson, and A Guerra, and P Clifford, and S Singh, and A Demissie, and A Svedmyr
Cytogenetic studies on Burkitt's lymphoma-leukemia.
November 1982, Cancer genetics and cytogenetics,
Copied contents to your clipboard!